University of Massachusetts Chan Medical School: SiRNA Therapy Has Potential to Halt Vision Loss in Age-related Macular Degeneration
May 28, 2026
May 28, 2026
WORCESTER, Massachusetts, May 28 (TNSjou) -- The University of Massachusetts Chan Medical School issued the following news:
* * *
New siRNA therapy has potential to halt vision loss in age-related macular degeneration
By Pat Sargent
New research out of UMass Chan Medical School reveals how a gene-silencing therapy targeting age-related macular degeneration (AMD), a leading cause of visual impairment in older adults, could potentially pause visu . . .
* * *
New siRNA therapy has potential to halt vision loss in age-related macular degeneration
By Pat Sargent
New research out of UMass Chan Medical School reveals how a gene-silencing therapy targeting age-related macular degeneration (AMD), a leading cause of visual impairment in older adults, could potentially pause visu . . .